While the loss of MHC and decrease of NK activity are fundamental for CTVT growth [76], further studies comparing different phases of the tumour’s growth, CTLA-4 expression in the tumour and local immune cells, and gene expression of CTLA-4 may provide more reliable evidence of CTVT immune escape. The gene discussed is CTLA4; the disease is neoplasm.